NCT00127166View on ClinicalTrials.gov

Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)

PHASE3CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Exercise Induced Asthma

Interventions

DRUG

Montelukast sodium

Montelukast 5 mg chewable tablet once daily

DRUG

Salmeterol xinafoate

Salmeterol 50 mcg dry powder per actuation inhaled twice daily

DRUG

Fluticasone propionate

Fluticasone (50 mcg per actuation) 100 mcg inhaled twice daily

DRUG

Montelukast matching placebo

Matching placebo to montelukast oral tablet administered once daily.

DRUG

Salmeterol matching placebo

Matching placebo to salmeterol dry powder for inhalation administered twice daily

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00127166 - Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911) | Biotech Hunter | Biotech Hunter